Table 1.
Quantitative cell viability.
| Group | Treatment | Cell viability (%) | Absorbance (570 nm) | Significance |
|---|---|---|---|---|
| G1 | Control | 100 ± 2.8 | 0.98 ± 0.03 | — |
| G2 | LPS (Inflammatory Control) | 62.4 ± 3.1 | 0.61 ± 0.02 | — |
| G3 | LPS + Probiotic Metabolites (25%) | 74.8 ± 2.6 | 0.73 ± 0.03 | * |
| G4 | LPS + Probiotic Metabolites (50%) | 86.3 ± 2.4 | 0.85 ± 0.02 | ** |
| G5 | LPS + Probiotic Metabolites (75%) | 92.7 ± 2.1 | 0.91 ± 0.03 | ** |
| G6 | LPS + Mixed Probiotic Metabolite Consortium | 95.4 ± 1.9 | 0.94 ± 0.02 | ** |
Values are presented as mean ± standard deviation from three independent biological replicates (n = 3), each analyzed in technical triplicate. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test (*p < 0.05, **p < 0.01 vs. G2).